IN2015MN00140A - - Google Patents
Download PDFInfo
- Publication number
- IN2015MN00140A IN2015MN00140A IN140MUN2015A IN2015MN00140A IN 2015MN00140 A IN2015MN00140 A IN 2015MN00140A IN 140MUN2015 A IN140MUN2015 A IN 140MUN2015A IN 2015MN00140 A IN2015MN00140 A IN 2015MN00140A
- Authority
- IN
- India
- Prior art keywords
- status
- individual
- tuberculosis infection
- tuberculosis
- present
- Prior art date
Links
- 201000008827 tuberculosis Diseases 0.000 abstract 7
- 208000015181 infectious disease Diseases 0.000 abstract 6
- 238000000034 method Methods 0.000 abstract 4
- 101900287970 Mycobacterium tuberculosis Alanine dehydrogenase Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000013517 stratification Methods 0.000 abstract 1
- 238000011285 therapeutic regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/55—IL-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
- G01N2333/90605—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
- G01N2333/90611—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1) in general
- G01N2333/90616—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1) in general with a definite EC number (1.4.1.-)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12176506.9A EP2687848A1 (en) | 2012-07-16 | 2012-07-16 | Status of tuberculosis infection in an individual |
| PCT/EP2013/065002 WO2014012928A1 (en) | 2012-07-16 | 2013-07-16 | Status of tuberculosis infection in an individual |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015MN00140A true IN2015MN00140A (enExample) | 2015-10-16 |
Family
ID=48795573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN140MUN2015 IN2015MN00140A (enExample) | 2012-07-16 | 2013-07-16 |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP2687848A1 (enExample) |
| CN (1) | CN104541169B (enExample) |
| AU (1) | AU2013292040B2 (enExample) |
| CA (1) | CA2878497C (enExample) |
| DK (1) | DK2872896T3 (enExample) |
| EA (1) | EA030721B1 (enExample) |
| ES (1) | ES2666073T3 (enExample) |
| IN (1) | IN2015MN00140A (enExample) |
| NO (1) | NO2872896T3 (enExample) |
| PL (1) | PL2872896T3 (enExample) |
| PT (1) | PT2872896T (enExample) |
| WO (1) | WO2014012928A1 (enExample) |
| ZA (1) | ZA201500254B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3171170A1 (en) * | 2015-11-17 | 2017-05-24 | Lionex GmbH | Device for use in elispot |
| KR20180104038A (ko) * | 2016-01-20 | 2018-09-19 | 시아먼 유니버시티 | 활동성 결핵의 진단을 위한 방법 및 키트 |
| CN106501530A (zh) * | 2017-01-05 | 2017-03-15 | 复旦大学附属华山医院 | 一种诊断结核杆菌感染的生物标志物及其相关试剂盒 |
| RU2726789C1 (ru) * | 2020-01-17 | 2020-07-15 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ФПИ" Минздрава России) | Способ иммунологического определения активности туберкулезной инфекции у детей и подростков с латентной инфекцией |
| CN115598353B (zh) * | 2022-10-24 | 2024-09-13 | 首都医科大学附属北京胸科医院 | 细胞因子作为标记物在制备肺外结核诊断或治疗预后产品中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6641814B1 (en) * | 1997-04-02 | 2003-11-04 | Statens Serum Institut | Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis |
| CA2279255A1 (en) | 1997-01-29 | 1998-08-20 | Flohe, Leopold | Test kit for tuberculosis diagnosis by determining alanine dehydrogenase |
| JP5017269B2 (ja) * | 2005-07-26 | 2012-09-05 | ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ | 結核状態に特有の抗体プロフィール |
| DE102007052518A1 (de) * | 2007-10-29 | 2009-04-30 | Autoimmun Diagnostika Gmbh | Verfahren zur in vitro-Diagnose und/oder in vitro- Therapieverfolgung von Infektionen |
| CN102033129A (zh) * | 2009-09-29 | 2011-04-27 | 上海英伯肯医学生物技术有限公司 | 用抗原刺激的细胞免疫反应来检测病原微生物的方法及测试笔 |
-
2012
- 2012-07-16 EP EP12176506.9A patent/EP2687848A1/en not_active Withdrawn
-
2013
- 2013-07-16 EA EA201590220A patent/EA030721B1/ru not_active IP Right Cessation
- 2013-07-16 PT PT137378311T patent/PT2872896T/pt unknown
- 2013-07-16 DK DK13737831.1T patent/DK2872896T3/en active
- 2013-07-16 NO NO13737831A patent/NO2872896T3/no unknown
- 2013-07-16 WO PCT/EP2013/065002 patent/WO2014012928A1/en not_active Ceased
- 2013-07-16 IN IN140MUN2015 patent/IN2015MN00140A/en unknown
- 2013-07-16 EP EP13737831.1A patent/EP2872896B1/en active Active
- 2013-07-16 CA CA2878497A patent/CA2878497C/en not_active Expired - Fee Related
- 2013-07-16 AU AU2013292040A patent/AU2013292040B2/en not_active Ceased
- 2013-07-16 CN CN201380038250.8A patent/CN104541169B/zh not_active Expired - Fee Related
- 2013-07-16 ES ES13737831.1T patent/ES2666073T3/es active Active
- 2013-07-16 PL PL13737831T patent/PL2872896T3/pl unknown
-
2015
- 2015-01-14 ZA ZA2015/00254A patent/ZA201500254B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014012928A1 (en) | 2014-01-23 |
| EP2687848A1 (en) | 2014-01-22 |
| AU2013292040B2 (en) | 2018-07-12 |
| CN104541169A (zh) | 2015-04-22 |
| NO2872896T3 (enExample) | 2018-05-26 |
| ZA201500254B (en) | 2016-06-29 |
| PL2872896T3 (pl) | 2018-08-31 |
| DK2872896T3 (en) | 2018-04-09 |
| EA201590220A1 (ru) | 2015-06-30 |
| PT2872896T (pt) | 2018-04-02 |
| CA2878497C (en) | 2021-06-08 |
| EP2872896B1 (en) | 2017-12-27 |
| ES2666073T3 (es) | 2018-04-30 |
| EP2872896A1 (en) | 2015-05-20 |
| CA2878497A1 (en) | 2014-01-23 |
| EA030721B1 (ru) | 2018-09-28 |
| CN104541169B (zh) | 2017-09-15 |
| AU2013292040A1 (en) | 2015-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ630421A (en) | Biomarkers predictive for clinical response for glatiramer acetate | |
| IN2015MN00140A (enExample) | ||
| MX2013000917A (es) | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. | |
| MX2013000916A (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. | |
| BR112014024219A8 (pt) | Métodos de determinação, de otimização da eficácia terapêutica, de monitoramento, de seleção de terapia e de diagnóstico de distúrbio e kit | |
| WO2011156468A8 (en) | A method of predicting clinical outcomes for melanoma patients using circulating melanoma cells in blood | |
| MX343324B (es) | Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha. | |
| WO2012094550A3 (en) | Assays and methods of treatment relating to vitamin d insufficiency | |
| WO2013080050A3 (en) | Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor | |
| MX2013003929A (es) | Biomarcadores de citoquina como marcadores predictivos de respuesta clinica para acetato de glatiramer. | |
| MX2015006852A (es) | Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica. | |
| IN2014DN08537A (enExample) | ||
| IN2014MN02101A (enExample) | ||
| WO2014078468A3 (en) | Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent | |
| MX2014002030A (es) | Biomarcadores de carcinoma de celulas renales y usos de los mismos. | |
| EP2882447A4 (en) | PROCESS FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF MUSCLE DYSTROPHY | |
| WO2012004276A3 (en) | Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits | |
| WO2013066879A3 (en) | SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE | |
| JP2014501929A5 (enExample) | ||
| WO2014023808A3 (en) | Method for evaluating a cancer patient for propensity to respond to a therapy | |
| AU2012264688A8 (en) | Methods for diagnosing multiple sclerosis | |
| WO2012008747A3 (ko) | 피부 진단 방법 및 키트 | |
| EP2614374A4 (en) | METHOD AND KITS FOR DETECTING INFECTION IN PEOPLE WITH LOW SPECIFIC ANTIBODY MIRRORS | |
| MX2015007494A (es) | Metodo para diagnosticar leucodistrofia metacromatica. | |
| MX362212B (es) | Metodo para la deteccion de mutaciones de braf y pi3k. |